Company · CIK 0001641281 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Bolt Biotherapeutics, Inc. · BOLT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 SForm 4 → | Sep 21, 6:05 pm EDT | Grant YonehiroChief Operating Officer | 13,176 | $3.32 | $43,807 | 17,269 | −43.3% | late |
| Sep 16, 2026 SForm 4 → | Sep 21, 6:04 pm EDT | Sarah NemecSenior VP, Finance and PAO | 7,842 | $3.32 | $26,072 | 17,082 | −31.5% | late |
| Sep 16, 2026 SForm 4 → | Sep 21, 6:03 pm EDT | William P. QuinnPresident, CEO and CFO, Director | 17,566 | $3.32 | $58,402 | 25,384 | −40.9% | late |
| Jun 5, 2026 PForm 4 → | Sep 21, 6:04 pm EDT | Sarah NemecSenior VP, Finance and PAO | 509 | $3.88 | $1,973 | 1,924 | +36.0% | late |
| Jun 5, 2026 PForm 4 → | Sep 21, 6:03 pm EDT | William P. QuinnPresident, CEO and CFO, Director | 637 | $3.88 | $2,469 | 2,950 | +27.5% | late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 AForm 4 → | Jun 11, 4:15 pm EDT | Laura BernerDirector | 5,000 | — | — | 5,000 | — | |
| Jun 10, 2026 AForm 4 → | Jun 11, 4:14 pm EDT | Kathleen LaporteDirector | 5,000 | — | — | 5,000 | — | |
| Jun 10, 2026 AForm 4 → | Jun 11, 4:12 pm EDT | Jakob DupontDirector | 5,000 | — | — | 5,000 | — | |
| Jun 10, 2026 AForm 4 → | Jun 11, 4:10 pm EDT | Brian O'CallaghanDirector | 5,000 | — | — | 5,000 | — | |
| Jun 10, 2026 AForm 4 → | Jun 11, 4:07 pm EDT | Nicole OnettoDirector | 5,000 | — | — | 5,000 | — |